BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors

PACULOVA, H., J. KRAMARA, S. SIMECKOVA, R. FEDR, K. SOUCEK, O. HYLSE, K. PARUCH, M. SVOBODA, M. MISTRÍK, J. KOHOUTEK
BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors. Tumor Biology. 2017, 39(10), 1010428317727479, ISSN: 1010-4283, PMID: 29025359,